In general, scores developed to evaluate the stage of fibrosis in patients with viral hepatitis (APRI, FIB-4, and AST/ALT) revealed low sensitivities and PPVs with an AUROC maximum of 0.586 for the APRI and FIB-4 and 0.503 for the AST/ALT. The gene discussed is GPT; the disease is viral hepatitis.